{
    "2018-12-09": [
        [
            {
                "time": "",
                "original_text": "微评丨医疗影响力排行榜：复星医药、贵州百灵、万东医疗",
                "features": {
                    "keywords": [
                        "医疗",
                        "影响力",
                        "排行榜",
                        "复星医药",
                        "贵州百灵",
                        "万东医疗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "带量采购引发医药股“雪崩” 2019年行业板块将如何演绎",
                "features": {
                    "keywords": [
                        "带量采购",
                        "医药股",
                        "雪崩",
                        "2019年",
                        "行业板块"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药板块的“至暗时刻”！“4+7”带量采购降价幅度远超市场预期！恒瑞医药蒸发百亿",
                "features": {
                    "keywords": [
                        "医药板块",
                        "至暗时刻",
                        "4+7",
                        "带量采购",
                        "降价",
                        "市场预期",
                        "恒瑞医药"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}